Resultados de procura - Atadja, Peter
- Mostrando 1 - 20 Resultados de 38
- Go to Next Page
-
1
Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells por Zhou, Qun, Agoston, Agoston T., Atadja, Peter, Nelson, William G., Davidson, Nancy E.
Publicado 2008Text -
2
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer por Venkannagari, Sreedhar, Fiskus, Warren, Peth, Karissa, Atadja, Peter, Hidalgo, Manuel, Maitra, Anirban, Bhalla, Kapil N.
Publicado 2012Text -
3
Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells por Yu, Chunrong, Friday, Bret B., Yang, Lin, Atadja, Peter, Wigle, Dennis, Sarkaria, Jann, Adjei, Alex A.
Publicado 2008Text -
4
-
5
Role of histone deacetylase inhibitor-induced ROS and DNA damage in LAQ-824/fludarabine antileukemic interactions por Rosato, Roberto R., Almenara, Jorge A., Maggio, Sonia C., Coe, Stefanie, Atadja, Peter, Dent, Paul, Grant, Steven
Publicado 2008Text -
6
Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemi... por Salmon, Jessica M, Bots, Michael, Vidacs, Eva, Stanley, Kym L, Atadja, Peter, Zuber, Johannes, Johnstone, Ricky W
Publicado 2015Text -
7
Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute... por Salmon, Jessica M., Bots, Michael, Vidacs, Eva, Stanley, Kym L., Atadja, Peter, Zuber, Johannes, Johnstone, Ricky W.
Publicado 2020Text -
8
-
9
Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy por Yang, Yonghua, Fiskus, Warren, Yong, Bao, Atadja, Peter, Takahashi, Yoshinori, Pandita, Tej K., Wang, Hong-Gang, Bhalla, Kapil N.
Publicado 2013Text -
10
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph(−) acute lymphoblastic leukemia cells por Scuto, Anna, Kirschbaum, Mark, Kowolik, Claudia, Kretzner, Leo, Juhasz, Agnes, Atadja, Peter, Pullarkat, Vinod, Bhatia, Ravi, Forman, Stephen, Yen, Yun, Jove, Richard
Publicado 2008Text -
11
Concurrent HDAC and mTORC1 Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated with Alterations in MicroRNA Expression por Ellis, Leigh, Lehet, Kristin, Ramakrishnan, Swathi, Adelaiye, Remi, Miles, Kiersten M., Wang, Dan, Liu, Song, Atadja, Peter, Carducci, Michael A., Pili, Roberto
Publicado 2011Text -
12
Involvement of Histone Acetylation of Sox17 and Foxa2 Promoters during Mouse Definitive Endoderm Differentiation Revealed by MicroRNA Profiling por Fu, Shijun, Fei, Qi, Jiang, Hua, Chuai, Shannon, Shi, Song, Xiong, Wen, Jiang, Lei, Lu, Chris, Atadja, Peter, Li, En, Shou, Jianyong
Publicado 2011Text -
13
Histone Deacetylase Inhibitors Activate NF-κB in Human Leukemia Cells through an ATM/NEMO-related Pathway por Rosato, Roberto R., Kolla, Sarah S., Hock, Stefanie K., Almenara, Jorge A., Patel, Ankita, Amin, Sanjay, Atadja, Peter, Fisher, Paul B., Dent, Paul, Grant, Steven
Publicado 2010Text -
14
Structure of Human SMYD2 Protein Reveals the Basis of p53 Tumor Suppressor Methylation por Wang, Li, Li, Ling, Zhang, Hailong, Luo, Xiao, Dai, Jingquan, Zhou, Shaolian, Gu, Justin, Zhu, Jidong, Atadja, Peter, Lu, Chris, Li, En, Zhao, Kehao
Publicado 2011Text -
15
Histone deacetylase inhibitors activate NF-κB in human leukemia cells through an ATM/NEMO-related pathway. por Rosato, Roberto R., Kolla, Sarah S., Hock, Stefanie K., Almenara, Jorge A., Patel, Ankita, Amin, Sanjay, Atadja, Peter, Fisher, Paul B., Dent, Paul, Grant, Steven
Publicado 2016Text -
16
Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells por Catley, Laurence, Weisberg, Ellen, Kiziltepe, Tanyel, Tai, Yu-Tzu, Hideshima, Teru, Neri, Paola, Tassone, Pierfrancesco, Atadja, Peter, Chauhan, Dharminder, Munshi, Nikhil C., Anderson, Kenneth C.
Publicado 2006Text -
17
Polycomb Target Genes Are Silenced in Multiple Myeloma por Kalushkova, Antonia, Fryknäs, Mårten, Lemaire, Miguel, Fristedt, Charlotte, Agarwal, Prasoon, Eriksson, Maria, Deleu, Sarah, Atadja, Peter, Österborg, Anders, Nilsson, Kenneth, Vanderkerken, Karin, Öberg, Fredrik, Jernberg-Wiklund, Helena
Publicado 2010Text -
18
THE ANTI-MELANOMA ACTIVITY OF THE HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT (LBH589) IS MEDIATED BY DIRECT TUMOR CYTOTOXICITY AND INCREASED TUMOR IMMUNOGENICITY por Woods, David M., Woan, Karrune, Cheng, Fengdong, Wang, Hongwei, Perez-Villarroel, Patricio, Lee, Calvin, Lienlaf, Maritza, Atadja, Peter, Seto, Edward, Weber, Jeffrey, Sotomayor, Eduardo M., Villagra, Alejandro
Publicado 2013Text -
19
Superior efficacy of a combined epigenetic therapy against human Mantle Cell Lymphoma (MCL) cells por Fiskus, Warren, Rao, Rekha, Balusu, Ramesh, Ganguly, Siddhartha, Tao, Jianguo, Sotomayor, Eduardo, Mudunuru, Uma, Smith, Jacqueline E., Hembruff, Stacey L., Atadja, Peter, Marquez, Victor E., Bhalla, Kapil
Publicado 2012Text -
20
Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of a Novel Histone Deacetylase Inhibitor, LAQ824, in Human Colon Carcinoma Cells and Xenografts por Chung, Yuen-Li, Troy, Helen, Kristeleit, Rebecca, Aherne, Wynne, Jackson, L Elizabeth, Atadja, Peter, Griffiths, John R, Judson, Ian R, Workman, Paul, Leach, Martin O, Beloueche-Babari, Mounia
Publicado 2008Text